Retatrutides ~24.2% (48 wk, 12 mg monotherapy) and cagrilintides ~10.8% (26 wk, 4.5 mg monotherapy) differ in duration and dose, and cagrilintides strongest data are combination (CagriSema) data
This guide covers the complete amylin receptor agonist class including natural amylin's physiological role, how synthetic agonists improve upon nature, cagrilintide vs pramlintide (next-gen vs first-gen), mechanism comparison to GLP-1 and GIP agonists, clinical weight loss data, dosing protocols, side effect profiles, and combination therapy strategies for maximum results
Always consult with a healthcare provider before starting any new supplement, especially peptides
While not hair-specific, their tissue repair properties may support overall follicle health, particularly following microneedling-induced wounds